AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2020
Dec 3, 2020
33298_dirs_2020-12-03_f9a855db-c75b-455e-851d-a48290244acf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: CONVERSION LABS, INC. (CVLB)
CIK: 0000948320
Period of Report: 2020-11-20
Reporting Person: Yecies Eric Harold (Chief Compliance Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Options to purchase shares of Common Stock | $ | Common Stock, par value $0.001 (200000) | Direct |
Footnotes
F1: Pursuant to the terms of the employment agreement, by and between Mr. Yecies and the Issuer, Mr. Yecies received a Stock Option (the "Stock Option") to purchase up to 200,000 shares of the Company's common stock at an exercise price of $7.55 per share.
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17